Characteristics and outcome of influenza-associated encephalopathy/encephalitis among children in China
Min Yang1, Ling Yi2, Fenglin Jia3
1Department of Pediatric Intensive Care Unit, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China; Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, Sichuan, China.
Insights
Influenza-Associated Encephalopathy/Encephalitis (IAE) in children has a high mortality rate. Factors like low Glasgow coma score and underlying conditions increase poor prognosis risk, highlighting the importance of influenza vaccination.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Neuroscience
Background:
- Influenza-Associated Encephalopathy/Encephalitis (IAE) presents a significant clinical challenge due to its high incidence and poor prognosis in pediatric populations.
- Understanding the clinical spectrum and outcomes of IAE is crucial for improving patient management and outcomes.
Purpose of the Study:
- To delineate the clinical characteristics, treatment modalities, and survival outcomes of pediatric patients diagnosed with Influenza-Associated Encephalopathy/Encephalitis.
- To identify key factors associated with mortality and poor prognosis in children affected by IAE.
Main Methods:
- A retrospective review was conducted on hospitalized pediatric cases with laboratory-confirmed influenza infection between January 2018 and December 2021.
- Data collected included demographics, clinical presentation, neuroimaging findings, treatments administered, and patient outcomes. Statistical analysis was performed to identify significant associations.
Main Results:
- Out of 446 children hospitalized with influenza, 71 cases of IAE were identified. The majority of affected children were under 5 years old, and only one patient had received seasonal influenza vaccination.
- Abnormal electroencephalogram (EEG) and brain magnetic resonance imaging (MRI) or computed tomography (CT) findings were prevalent in over 64% of patients. Antiviral treatment with oseltamivir or peramivir was administered to 95.8% of patients.
- The mortality rate for IAE was 16.9%. Non-survivors were significantly associated with lower Glasgow coma scores, prolonged fever duration, underlying medical conditions, and a higher incidence of complications such as sepsis, shock, respiratory failure, and myocardial damage.
Conclusions:
- Influenza-Associated Encephalopathy/Encephalitis carries a substantial mortality risk in children.
- Lower Glasgow coma score, extended fever duration, pre-existing medical conditions, and the presence of complications are critical indicators of poor prognosis.
- Influenza vaccination is strongly recommended for all eligible children to mitigate the risk of IAE and its severe consequences.
Background:
Influenza-Associated Encephalopathy/Encephalitis (IAE) is characterized by high incidence and poor prognosis. The aim of this study is to describe the clinical features and outcomes of IAE in pediatric patients.
Methods:
We performed a retrospective review of hospitalized cases of laboratory-confirmed influenza infection between January 2018 and December 2021. Demographic, clinical, imaging, treatment and outcome data were collected. Statistical analysis was performed using SPSS software.
Results:
Of 446 children hospitalized with influenza, 71 cases were identified with a diagnosis of IAE. The median age was 3 years and 46 (64.8 %) were younger than 5 years. Only one patient was vaccinated for seasonal influenza. 46 (64.8 %) patients had abnormal electroencephalogram examination and 47 (66.2 %) had abnormal brain MRI or CT findings. 68 (95.8 %) patients were treated with oseltamivir/peramivir. 12 (16.9 %) patients suffered mortality. Non-survivors were more likely to have lower Glasgow coma score (median 7), longer duration of fever (median 3 days), with underlying medical conditions (P = 0.006), and complications including sepsis (P = 0.003), shock (P < 0.001), respiratory failure (P = 0.006), acute renal failure (P = 0.001), myocardial damage (P < 0.001), coagulation disorders (P = 0.03), electrolyte disturbance (P = 0.001) and hyperlactacidemia (P = 0.003). Non-survivors had higher percentages of corticosteroids (P = 0.003) and immunoglobulin (P = 0.003) treatments compared to survivors.
Conclusions:
Children with IAE have a high mortality rate. Lower Glasgow coma score, longer duration of fever, with underlying medical conditions and complications pose a great risk to poor prognosis. Influenza vaccination is recommended to all eligible children.
More Related Videos
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
06:22Standardization of Transfer across Labs between Flow Cytometers for Detection of Lymphocytes in Japanese Encephalitis Vaccinated Children
Published on: February 10, 2023
Related Concept Videos
Viral Meningitis
Poliomyelitis
Arboviral Encephalitis
Influenza
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
